secwatch.observer — SEC 8-K summary
======================================

Issuer:     HALOZYME THERAPEUTICS, INC. (HALO)
CIK:        0001159036
Form:       8-K
Filed at:   2025-02-13T23:59:59+00:00
Accession:  0001159036-25-000005
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Halozyme director Connie Matsui to leave board after nearly 18 years
--------------------------------------------------------------------

- Connie Matsui notified Halozyme on Feb 11, 2025 she will not stand for reelection at the 2025 annual meeting.
- Matsui served on the board for nearly 18 years; departure is not due to any disagreement with the company.
- No replacement has been announced; the board thanked Matsui for her service.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1159036/000115903625000005/0001159036-25-000005-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1159036/000115903625000005/halo-20250211.htm
  HTML page:      https://secwatch.observer/filing/0001159036-25-000005

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer